Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
7
×
boston blog main
clinical trials
7
×
life sciences
national blog main
san diego blog main
7
×
boston top stories
fda
national top stories
new york blog main
san diego top stories
san francisco blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston
cancer
cancer immunotherapy
gene therapy
ipo
astrazeneca
biogen
celgene
dyne therapeutics
forty seven
merck
What
ipo
7
×
week
bio
biotechs
life
medicines
roundup
science
therapeutics
companies
company
drug
dyne
firms
genetic
ipos
million
muscle
public
raised
rare
sciences
acquisitions
ago
america
announced
arena’s
biogen
bounty
brings
ceo
chose
cig
close
club
collabs
comeback
considering
continued
continues
Language
unset
Current search:
biotech
×
" san diego blog main "
×
" clinical trials "
×
ipo
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M